Latest filing published 13 Oct 2026 for Ocugen, Inc., €397k. Read the official filing
Shankar Musunuri is a declared insider of Ocugen, Inc. (chief executive), with filings sourced from SEC (Form 4). The record holds 24 filings, for trades running from 3 May 2021 to 9 October 2026.
On the market, this insider has only sold: 6 sales, €2.3M in total. Outside the open market, there are 6 share grants and 12 option exercises. In 2026 alone, the filings show no purchases and 4 sales.
The record was last updated on 13 October 2026 with an open-market sale (€397k) in Ocugen, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
24 of 24 declarations